Commercial Planning Should Precede GPO Outreach

A medical device manufacturer may approach a group purchasing organization before answering some basic commercial questions. It might be known that hospitals buy through group contracts, but have no clear view of which facilities to target or how the sales process will work. Pricing limits and the level of internal support may also remain unsettled. Starting GPO discussions at this point often brings those gaps to the surface.

The company first needs to understand the market the device is entering. A product designed to replace an existing device will be compared with options hospitals already know. A device that introduces a different approach to care faces another task. The manufacturer may need to explain the category itself before a purchasing team is ready to discuss the product.

The target customer base also affects GPO planning. Access to a broad hospital network may sound   attractive, but facilities will not have the same reason to consider the device. Procedure volumes and purchasing authority vary between hospitals. Existing contracts and product review schedules can also influence whether an account is ready to evaluate an alternative. These differences should guide which GPO relationships the manufacturer pursues.

Pricing needs to be worked through before negotiations begin. Production cost may provide a starting   point, but it does not show the full expense of selling to hospitals. Staff education and account service add costs after the device is purchased. Order handling and product replacement can change the financial return further. Terms that appear workable during negotiations may become difficult to maintain once those expenses are included.

Commercialization services can help manufacturers connect these decisions before approaching a GPO. The work involves more than identifying a possible contracting route. A company needs to decide what it expects the agreement to achieve and whether its sales model can support the access it receives.

Supporting evidence must also fit the people reviewing the device. Clinical users are likely to consider how the product will be used in patient care. Procurement staff will have different questions about the purchase and its effect on existing arrangements. One presentation may not provide enough information for both discussions.

The company should also consider what will happen when a hospital shows interest. Someone must be available to respond to an evaluation request and arrange staff training. Early orders may also come from facilities outside the manufacturer’s current service area. If the business has not planned for those situations, contract access can produce interest that it is not prepared to support.

Timing is another judgment call. A manufacturer may pursue broad purchasing access before it has created   enough interest within individual hospitals. The opposite can happen when a company spends too long developing account-level demand but has no contracting route ready when buyers want to proceed. The right sequence depends on the way hospitals purchase that device category and the evidence already available from potential users.

For this reason, GPO planning should be part of the wider commercialization model rather than treated as a separate contracting exercise. The company needs a workable view of how the device will be positioned and which accounts it intends to pursue. It must also understand how much support it can provide and which financial terms it can accept.

The central question is not whether a manufacturer approaches a GPO early or late. It is whether the   business knows what it wants the agreement to do. Contract discussions have a clearer purpose when they support a defined hospital buying process instead of a broad ambition to gain market access.